Omegaven emulsion for infusion 50ml vials 영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

omegaven emulsion for infusion 50ml vials

fresenius kabi ltd - glycerol; egg phosphatide; fish oil - emulsion for infusion - 25mg/1ml ; 12mg/1ml ; 100mg/1ml

Omegaven emulsion for infusion 100ml vials 영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

omegaven emulsion for infusion 100ml vials

fresenius kabi ltd - fish oil; glycerol; egg phosphatide - emulsion for infusion - 100mg/1ml ; 25mg/1ml ; 12mg/1ml

OMEGAVEN 이스라엘 - 영어 - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

OMEGAVEN 이스라엘 - 영어 - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

OMEGAVEN 이스라엘 - 영어 - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 2463 mL 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: egg lecithin; glycerol; sodium oleate; water for injections; sodium hydroxide; dl-alpha-tocopherol - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1970 mL 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; water for injections; egg lecithin; dl-alpha-tocopherol; sodium hydroxide; glycerol - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 mL 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; dl-alpha-tocopherol; glycerol; egg lecithin; water for injections; sodium hydroxide - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; sodium oleate; egg lecithin; glycerol; water for injections; dl-alpha-tocopherol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 mL 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; dl-alpha-tocopherol; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.